Text size A - A+

enVista hydrophobic acrylic IOL

enVista is a new Glistening-free, hydrophobic acrylic IOL from Bausch + Lomb.



The enVista hydrophobic acrylic IOL is the first and only FDA-approved enVista IOL in the U.S. with labeling that states: “No glistenings of any grade were reported for any subject at any visit in the clinical study”.1-2

Glistenings are fluid-filled microvacuoles that can form within an IOL, and are common in some hydrophobic acrylic IOLs. They cause a portion of the light coming into the eye to be scattered in all directions, and have been shown to have a negative impact on visual acuity.3 Additionally, the enVista lens is designed to minimize Posterior Capsular Opacification (PCO), a common post-surgical complication with IOLs that cause vision to become clouded post-surgery.

Introducing BLIS for use with enVista!


BLIS-handpieceLearn more about BLIS (Bausch + Lomb Injector System), designed exclusively for use with the enVista IOL. BLIS, complete with a reusable hand piece and single-use cartridge, allows surgeons secure, controlled delivery of the enVista IOL through unenlarged phaco incisions as small as 2.2 mm. 


Key Features & Benefits

Give your patients long-term clarity and quality of vision2-10
  • No glistenings were reported at any time in controlled clinical studies1,3,4
  • Aberration-free aspheric Advanced Optics8-10
  • Designed to minimize PCO11

Exceptional quality of vision


  • Glistenings are prevented and material stability enhanced by:
    • glisteningsHydrating the lens to equilibrium water content so that it will neither gain nor lose water
    • Packaging the lens in 0.9% saline solution to eliminate fluid exchange with the aqueous humor3,5-7
  • Abrasion resistance is increased due to improved surface durability7
  • Hydrophobic properties are maintained over time5
  • Enhanced contrast sensitivity; uniform power, center to edge; and better vision quality are delivered by Bausch + Lomb aspheric, aberration-free Advanced Optics8-10

 

Designed to minimize PCO


  • Step-vaulted haptics are designed to vault the optic posteriorly for direct contact with the capsular bag
  • LEC migration inhibited by 360° square barrier edge11 

stability

Stability and advanced control


  • 100% of patients had ≤ 5° of IOL rotation between days 30 and 1801
  • Precise positioning in the capsular bag and removal of viscoelastic are facilitated by controlled unfolding

enVista IOL : Additional information

See references
Introducing BLIS for enVista
Improved control is BLIS (Bausch + Lomb BLIS Injector System)

BLIS for enVista

BLIS Injector System

enVista Testimonials

DeeStephenson"I would recommend enVista to any colleague who has not yet tried this outstanding IOL. enVista delivers glistening-free clarity, low PCO, and the pristine optics that every surgeon wants for their cataract surgery patients."

P. Dee Stephenson, MD, FACS
Venice, Florida

 

FarrellTyson"The enVista lens platform combines glistening-free, scratch resistance, and an aberration-free design in a hydrophobic acrylic material that not only provides for beautiful post op day one results but for a lifetime of excellent vision."

Farrell “Toby” Tyson, MD 
Ft. Myers, Florida

 

JamesKhodabakhsh"The optical clarity of enVista is outstanding. Plus, it has the added benefit of a controlled opening that enables surgeons to effectively remove viscoelastic from behind the lens."

A. James Khodabakhsh, MD
Beverly Hills, CA

 

DavidAGoldman"For my pseudoexfoliation patients, enVista is my first and only choice of lens because of its near- CTR-like rigidity and zero-aberration design."

David A Goldman, MD
Palm Beach Gardens, FL